106 related articles for article (PubMed ID: 10319121)
1. Nalidixic acid prodrugs: amides from amino acid ester and nalidixic acid.
Taori A; Nema R; Kohli DV; Uppadhyay RK
Arch Pharm Res; 1991 Mar; 14(1):48-51. PubMed ID: 10319121
[TBL] [Abstract][Full Text] [Related]
2. Nalidixic acid prodrugs: amides from amino acid esters and nalidixic acid.
Kohli DV; Uppadhyay RK; Saraf SK; Vishwakarma KK
Pharmazie; 1992 Jan; 47(1):57-9. PubMed ID: 1608986
[No Abstract] [Full Text] [Related]
3. Synthesis and in vitro investigations of nalidixic acid amides of amino acid esters as prodrugs.
Aboul-Fadl T; Fouad EA
Pharmazie; 1996 Jan; 51(1):30-3. PubMed ID: 8999431
[TBL] [Abstract][Full Text] [Related]
4. Researches on antibacterial and antifungal agents. I. Analogs of nalidixic acid with a pyrrole moiety.
Corelli F; Massa S; Stefancich G; Artico M; Panico S; Simonetti N
Farmaco Sci; 1983 Apr; 38(4):219-31. PubMed ID: 6861999
[TBL] [Abstract][Full Text] [Related]
5. Towards calixarene-based prodrugs: Drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct.
Dibama HM; Clarot I; Fontanay S; Salem AB; Mourer M; Finance C; Duval RE; Regnouf-de-Vains JB
Bioorg Med Chem Lett; 2009 May; 19(10):2679-82. PubMed ID: 19395263
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, primary photophysical and antibacterial properties of naphthyl ester cinoxacin and nalidixic acid derivatives.
Vargas F; Zoltan T; Rivas C; Ramirez A; Cordero T; Díaz Y; Izzo C; Cárdenas YM; López V; Gómez L; Ortega J; Fuentes A
J Photochem Photobiol B; 2008 Aug; 92(2):83-90. PubMed ID: 18562206
[TBL] [Abstract][Full Text] [Related]
7. Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.
Peraman R; Varma RV; Reddy YP
Bioorg Med Chem Lett; 2015 Oct; 25(19):4314-9. PubMed ID: 26277407
[TBL] [Abstract][Full Text] [Related]
8. Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?
Irfan S; Jabeen K; Jilani UA; Ahmed B; Mehraj J; Ahsan T; Zafar A
J Infect Dev Ctries; 2012 Oct; 6(10):700-3. PubMed ID: 23103891
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds.
Stevens PJ
J Antimicrob Chemother; 1980 Jul; 6(4):535-42. PubMed ID: 6159344
[No Abstract] [Full Text] [Related]
10. Efficient approach to acyloxymethyl esters of nalidixic acid and in vitro evaluation as intra-ocular prodrugs.
Azéma J; Guidetti B; Malet-Martino M; Martino R; Roques C
Bioorg Med Chem; 2006 Apr; 14(8):2569-80. PubMed ID: 16414264
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial evaluation of 1,2,3,4-tetrahydro-4-oxo-1,8-naphthyridine-3-carboxylic acid esters, carbonitriles, and carboxamides.
Santilli AA; Scotese AC; Yurchenco JA
J Med Chem; 1975 Oct; 18(10):1038-41. PubMed ID: 1099201
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents.
Grover G; Kini SG
Eur J Med Chem; 2006 Feb; 41(2):256-62. PubMed ID: 16260068
[TBL] [Abstract][Full Text] [Related]
14. A prodrug approach toward the development of water soluble fluoroquinolones and structure--activity relationships of quinoline-3-carboxylic acids.
Baker WR; Cai S; Dimitroff M; Fang L; Huh KK; Ryckman DR; Shang X; Shawar RM; Therrien JH
J Med Chem; 2004 Sep; 47(19):4693-709. PubMed ID: 15341485
[TBL] [Abstract][Full Text] [Related]
15. Activity of distamycin A on the transfer of drug resistance in gram-negative clinical isolates.
Sanfilippo A
Ann N Y Acad Sci; 1971 Jun; 182():322-8. PubMed ID: 4936668
[No Abstract] [Full Text] [Related]
16. Synthesis of novel nitroreductase enzyme-activated nitric oxide prodrugs to site-specifically kill bacteria.
Hibbard HAJ; Reynolds MM
Bioorg Chem; 2019 Dec; 93():103318. PubMed ID: 31586703
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structural analysis and antibacterial activity of a butyl ester derivative of ampicillin.
Bartzatt R; Malesa C
Chemotherapy; 2003 Sep; 49(5):213-21. PubMed ID: 14504431
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal.
Khanal B; Sharma SK; Bhattacharya SK; Bhattarai NR; Deb M; Kanungo R
J Health Popul Nutr; 2007 Mar; 25(1):82-7. PubMed ID: 17615907
[TBL] [Abstract][Full Text] [Related]
19. Development of antibacterial agents of the nalidixic acid type.
Albrecht R
Prog Drug Res; 1977; 21():9-104. PubMed ID: 339272
[No Abstract] [Full Text] [Related]
20. Nalidixic acid-resistant Salmonella typhi in Mumbai.
Rodrigues C; Mehta A; Joshi VR
Natl Med J India; 1999; 12(2):88. PubMed ID: 10416332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
